The Lung Cancer Alliance (LCA) has applauded the USFDA on its recent approval of Avastin (bevacizumab) for the most common type of lung cancer.
Laurie Fenton, President of Lung Cancer Alliance in Washington, D.C. stated:
“Lung cancer is responsible for over one-third of all U.S. cancer deaths, killing more people than breast, prostate, colon, liver and kidney cancers combined each year.
Sadly, we have few arrows in our treatment quiver to address this lethal killer. That is why the ability to use Avastin as a treatment method, along with chemotherapy, is a significant development for the lung cancer community.”

Manufactured by Genentech, Inc. (NYSE: DNA), …read more

The Cancer Cure Coalition has expressed its strong support for the nomination of Dr. Andrew Von Eschenbach as Commissioner of the U.S. Food and Drug Administration and called for the approval of Advexin, a new gene therapy treatment for cancer.
The Cancer Cure Coalition has the following sentiments:
We believe it critical that a permanent director be in charge of this vitally important agency and that he has the special experience and ability required to deal with the complex problems confronting it.
For too long this agency has lacked a permanent director and this has led to a slow down in its decision …read more